GettyImages-1054552164

We Exist to Help You Change Lives for a Better World

Our Values

Honorable

We do Right for Right's sake
We make decisions based on what’s right and wrong, not based on profit. That means clients are told when something is out of scope before we make any changes. We do everything in our power to treat customers, partners, and suppliers like we would like to be treated.

Results ++

We do the job and then some
It isn't enough to be average. It isn't enough to only "do the job". Our staff pride themselves in delighting clients with their work. We always strive to be that service experience where you walk away saying "WOW!". We aren't interested in doing just one project with a client. We are interested in decades of relationship fueled by Results++.

Humble Charisma

We strive to be the kind of people you want to be around
There are charismatic people that never stop talking about themselves. There are humble people that never get noticed. We strive for a perfect balance. At the end of an engagement, we hope that clients like our staff for who they are and not just what they have accomplished. We want to get to know them and hope they enjoy getting to know us. After all, businesses are made up of people, and working with others is what we like best!
iStock_70245107_XLARGE

World Class Innovation in Medical Devices

How We Help
Velentium = Velocity + Momentum + Ingenium

What's in a Name?

Active Implantable Medical Devices Velentium
VELocity: We believe our pace is staggering. Our staff not only understands the necessity of working fast, but enjoys it.
MomENTum: With a culture of continuity and consistency, you can be assured your project will maintain velocity to the finish with regular communication throughout all stages.
IngenIUM (Talent): We see talent as more than just the capability to complete technical tasks. We see talent as the ability to link technologies, understand your problem, ask penetrating questions, and guide the process from beginning to end.
Get Started Today!
Blog

Thought and Commentary for the Medical Device Industry

Velentium Announces Growth Recapitalization Led By Great Point Partners

Investment propels MedTech engineering firm’s planned global expansion and advancement of life-changing technologies HOUSTON, TX and GREENWICH, CT –...

Design for Manufacturing Part V - Pros and Cons

Velentium offers a selection of services that represents the entire lifecycle of a device. Our engineers, developers, SMEs, manufacturing...

Software Development Controls - Inputs

Welcome back to our blog series on Controlled Software Development for medical devices! In this post, we’ll look at the significant Input phases of...

Design Controls (Part 4): Design Outputs & Review

Design outputs are the result of each design phase and of the entire design effort. A completed and finished design will culminate in the device...

Velentium’s 2022 Speaking Engagement Schedule

June 20, 2022 | Posted by Lindsey Dinneen
Learn from Velentium's subject matter experts at their upcoming presentations. Check back for updates!

Spark Biomedical and Velentium Honored by Fast Company as a 2022 World Changing Idea for Their Partnership in Developing the Sparrow Therapy System™

May 4, 2022 | Posted by Lindsey Dinneen
The companies partnered to design, develop and manufacture the medical device technology that provides a wearable neurostimulation solution for opioid withdrawal relief

Health Sector Coordinating Council’s Recommendations for Enhanced MedTech Cybersecurity Receives Further Industry Endorsement

April 19, 2022 | Posted by Lindsey Dinneen
Velentium’s Director of Product Security helped draft industry standard

Velentium’s Director of Product Security to Speak on Cybersecurity at MD&M West

April 5, 2022 | Posted by Lindsey Dinneen
Christopher Gates will host presentations on a secure medical device development lifecycle and threat modeling for manufacturers

Case Study: Building a Partner Ecosystem to Win the Fight Against Opioid Withdrawal

March 9, 2022 | Posted by Lindsey Dinneen
Effective Opioid Response In the yearlong period ending April 2021, over 100,000 Americans died from drug overdose, the vast majority from synthetic opioids. An estimated 4 million of the 11 million...

2021 Awards Roundup

March 1, 2022 | Posted by Lindsey Dinneen
2021 was an exciting year for Velentium. Between receiving investment from Great Point Partners, expanding intelligent testing services in the energy sector, building bunk beds for Sleep in Heavenly...